Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Momordica Charantia for Insulin Sensitivity in Type 2 Diabetes
NCT02397447Phase 2Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Mar 2013
- Primary completion
- Nov 2015
- Modality
- Botanical Extract
- Countries
- 1
01
Overview
A Phase 2 trial of momordica charantia extract in type 2 diabetes mellitus (T2DM), sponsored by Universidad de Guadalajara. Started Mar 2013; status: completed.
02
Drugs
momordica charantia extract
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02397447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397447.